SCHEMBL637382

SCHEMBL637382

O=C(NCCn1cccn1)c1ccccc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 3/20 0.63
RAB9A P51151 2/20 0.57
BRD4 O60885 1/20 0.52
KMT2A Q03164 3/20 0.50
HDAC1 Q13547 2/20 0.50
EPHX2 P34913 2/20 0.50
HDAC6 Q9UBN7 1/20 0.50
SMN1; SMN2 Q16637 2/20 0.49
MEN1 O00255 1/20 0.49
NPC1 O15118 1/20 0.49
ALDH1A1 P00352 1/20 0.49
CYP1A2 P05177 1/20 0.49
HSP90AA1 P07900 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49
MAPT P10636 1/20 0.49
CYP2C9 P11712 1/20 0.49
PKM P14618 1/20 0.49
CYP2C19 P33261 1/20 0.49
NAAA Q02083 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29410988 0.90 NAAA (0.56) NAMPTRAB9ABRD4HDAC1HDAC6
SCHEMBL10612987 0.84 HDAC1 (0.52) NAMPTRAB9ABRD4KMT2AHDAC1
SCHEMBL29004722 0.80 KMT2A (0.47) NAMPTRAB9AKMT2AHDAC1HDAC6
SCHEMBL11726168 0.80 NAMPT (0.53) NAMPTRAB9AHDAC1HDAC6SMN1; SMN2
SCHEMBL9772620 0.79 NAMPT (0.59) NAMPTRAB9AKMT2AHDAC1EPHX2
SCHEMBL3707443 0.79 NAMPT (1.00) NAMPT
SCHEMBL29531015 0.78 NAMPT (0.54) NAMPTKMT2AHDAC1HDAC6SMN1; SMN2
SCHEMBL27176270 0.77 KMT2A (0.62) RAB9AKMT2AHDAC1HDAC6SMN1; SMN2
SCHEMBL27176255 0.76 NAMPT (0.47) NAMPTRAB9AKMT2AHDAC1HDAC6
SCHEMBL27176232 0.76 KMT2A (0.47) NAMPTRAB9AKMT2AHDAC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017144393-A1 2-SUBSTITUTED 5-(PHENYL)-1,2-DIHYDRO-3H-3-BENZAZEPINE-3-CARBOXAMIDE DERIVATIVES AS BRD4 INHIBITORS FOR THE TREATMENT OF CANCER BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2017-08-31 WO disclosed
EP-2420142-A1 Use of N-2-(pyrazolyl)ethylphenylcarboxamides or their salts for controlling powdery mildew primary infections Bayer CropScience AG (DE) 2012-02-22 EP disclosed
EP-2420142-A1 Use of N-2-(pyrazolyl)ethylphenylcarboxamides or their salts for controlling powdery mildew primary infections Bayer CropScience AG (DE) 2012-02-22 EP disclosed